Crossmark

A review of the bioelectronic implications of stimulation of the peripheral nervous system for chronic pain conditions

Crossref DOI link: https://doi.org/10.1186/S42234-020-00045-5

Published: 2020-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Deer, Timothy R.

Naidu, Ramana

Strand, Natalie

Sparks, Dawn

Abd-Elsayed, Alaa

Kalia, Hemant

Hah, Jennifer M.

Mehta, Pankaj

Sayed, Dawood

Gulati, Amitabh
License Information

Text and Data Mining valid from 2020-04-24
More Information

Article History

Received: 23 December 2019

Accepted: 24 March 2020

First Online: 24 April 2020

Ethics approval and consent to participate

: The manuscript is a review article and this is not applicable.

: All authors consent to publication as an original article.

: TRD: consultant for Axonics, Abbott, Nalu, Saluda, Medtronic, Nevro, Boston Scientific (Vertiflex), Vertos, Cornerloc, SPR Therapeutics, Flowonix. Stimgenics.RKN: Consultant for Abbott, Avanos, Bicycle Health, Boston Scientific, CereVu, ExerAI, KarunaVR, Nalu, Omnia Medical, Sonosite, SPR Therapeutics, Vertiflex, Vertos.NHS: nothing to declare.DS: nothing to declare.AA: consultant for Medtronic, StimWave, Avanos and Sollis.JMH: Nothing to declare.HK: nothing to declare.PM: Consultant for Abbott, CornerLoc SPR Therapeutics, Vertiflex, Ethos Labs.DS: Abbott, Flowonix, Medtronic, Nevro, PainTeq, SPR, Stimgenics, Vertos, Vertiflex.AG: Consultant for Medtronic, Flowonix, AIS, SPR Therapeutics, Nalu, EnsoRelief.